Cambridge Trust’s Covetrus, Inc. Common Stock CVET Stock Holding History

Cambridge Trust’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	–	–	916
2022 Q3	$0	Hold	1	–	–	﹤0.01%	918
2022 Q2	$0	Hold	1	–	–	﹤0.01%	977
2022 Q1	$0	Hold	1	–	–	﹤0.01%	1228
2021 Q4	$0	Buy	+1	New	+$19	﹤0.01%	1160

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cambridge Trust's CVET Position: Q4 2022 in Review

Cambridge Trust sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 1 share.

Cambridge Trust first reported a position in CVET in Q4 2021 and held it in 4 quarters. The position peaked at $0 in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Cambridge Trust reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cambridge Trust sold 1 Covetrus, Inc. Common Stock share in Q4 2022.
Cambridge Trust first reported a position in Covetrus, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Cambridge Trust's Covetrus, Inc. Common Stock position peaked at $0 in Q3 2022.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Cambridge Trust's 13F filing for Q4 2022, filed 10 Jan 2023.